The European Chemicals Agency (ECHA) has published recommended guidelines for conducting an analysis of alternatives (AoA) for active substances that are candidates for substitution.
By January 1, 2024, all manufacturers of biocidal products containing Chrysanthemum cinerariaefolium Extract must submit an application for authorization if they wish to continue selling their products.
The guidelines are used to demonstrating the effectiveness of biocidal products in the authorization process. However, the requirements defined in the document are also used by the Competent authorities in registration process in transitional period.
ECHA published the Biocidal Products Committee work programme for 2020, specifying substances with authorisation date expected to be published in 2020.